![Lions Clubs International MD101 Sverige - Lions cancerfond ((Mellansverige, Örebro & Uppsala) ger miljoner till cancerforskning vid Akademiska sjukhuset Lions Clubs International MD101 Sverige - Lions cancerfond ((Mellansverige, Örebro & Uppsala) ger miljoner till cancerforskning vid Akademiska sjukhuset](https://lions.se/images/images/forskning.jpg)
Lions Clubs International MD101 Sverige - Lions cancerfond ((Mellansverige, Örebro & Uppsala) ger miljoner till cancerforskning vid Akademiska sjukhuset
Early mortality after diagnosis of cancer of the head and neck – A population-based nationwide study | PLOS ONE
![The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma | Nature Communications The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-021-25332-w/MediaObjects/41467_2021_25332_Fig1_HTML.png)
The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma | Nature Communications
![The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma | Nature Communications The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-25332-w/MediaObjects/41467_2021_25332_Fig1_HTML.png)
The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma | Nature Communications
Determinants for Effective ALECSAT Immunotherapy Treatment on Autologous Patient-Derived Glioblastoma Stem Cells
![The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma | Nature Communications The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-021-25332-w/MediaObjects/41467_2021_25332_Fig3_HTML.png)
The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma | Nature Communications
![The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma | Nature Communications The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-021-25332-w/MediaObjects/41467_2021_25332_Fig2_HTML.png)
The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma | Nature Communications
![Preoperative overnight parenteral nutrition (TPN) improves skeletal muscle protein metabolism indicated by microarray algorithm analyses in a randomized trial - Iresjö - 2016 - Physiological Reports - Wiley Online Library Preoperative overnight parenteral nutrition (TPN) improves skeletal muscle protein metabolism indicated by microarray algorithm analyses in a randomized trial - Iresjö - 2016 - Physiological Reports - Wiley Online Library](https://physoc.onlinelibrary.wiley.com/cms/asset/e48c378c-b3a2-4494-ada9-4f458553f2ac/phy212789-fig-0002-m.png)